|
1.
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
|
|
2.
|
Wolpin BM, Meyerhardt JA, Mamon HJ and
Mayer RJ: Adjuvant treatment of colorectal cancer. CA Cancer J
Clin. 57:168–185. 2007. View Article : Google Scholar
|
|
3.
|
Sauer R, Becker H, Hohenberger W, et al:
Pre-operative versus postoperative chemoradiotherapy for rectal
cancer. N Engl J Med. 351:1731–1740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Calvo FA, Serrano FJ, Diaz-González JA, et
al: Improved incidence of pT0 downstaged surgical specimens in
locally advanced rectal cancer (LARC) treated with induction
oxaliplatin plus 5-fluorouracil and pre-operative chemoradiation.
Ann Oncol. 17:1103–1110. 2006. View Article : Google Scholar
|
|
5.
|
Ishii H, Iwatsuki M, Ieta K, et al: Cancer
stem cells and chemoradiation resistance. Cancer Sci. 99:1871–1877.
2008. View Article : Google Scholar
|
|
6.
|
Haraguchi N, Inoue H, Tanaka F, et al:
Cancer stem cells in human gastrointestinal cancers. Hum Cell.
19:24–29. 2006. View Article : Google Scholar
|
|
7.
|
Zlobec I, Vuong T and Compton CC: The
predictive value of apoptosis protease-activating factor 1 in
rectal tumors treated with pre-operative, high-dose-rate
brachytherapy. Cancer. 106:284–286. 2005. View Article : Google Scholar
|
|
8.
|
Negri FV, Campanini N, Camisa R, et al:
Biological predictive factors in rectal cancer treated with
pre-operative radiotherapy or radiochemotherapy. Br J Cancer.
98:143–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zlobec I, Vuong T, Compton CC, et al:
Combined analysis of VEGF and EGFR predicts complete tumour
response in rectal cancer treated with pre-operative radiotherapy.
Br J Cancer. 98:450–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Br J Cancer. 99:1285–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Haraguchi N, Ohkuma M, Sakashita H, et al:
CD133+CD24+ population efficiently enriches
colon cancer initiating cells. Ann Surg Oncol. 15:2927–2933.
2008.
|
|
12.
|
Choi D, Lee HW, Hur KY, et al: Cancer stem
cell markers CD133 and CD24 correlate with invasiveness and
differentiation in colorectal adenocarcinoma. World J
Gastroenterol. 15:2258–2264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
He XX, Chen K, Yang J, et al: Macrophage
migration inhibitory factor promotes colorectal cancer. Mol Med.
15:1–10. 2009.PubMed/NCBI
|
|
14.
|
Tanahashi J, Daa T, Gamachi A, et al:
Human intestinal spirochetosis in Japan; its incidence,
clinicopathologic features, and genotypic identification. Mod
Pathol. 21:76–84. 2008.
|
|
15.
|
Sato JD, Kawamoto T, Le AD, Mendelsohn J,
Polikoff J and Sato GH: Biological effects in vitro of monoclonal
antibodies to human epidermal growth factor receptors. Mol Biol
Med. 1:511–529. 1983.PubMed/NCBI
|
|
16.
|
Cheuk W, Wong KO, Wong CS and Chan JK:
Consistent immunostaining for cyclin D1 can be achieved on a
routine basis using a newly available rabbit monoclonal antibody.
Am J Surg Pathol. 28:801–807. 2004. View Article : Google Scholar
|
|
17.
|
Paik SS, Jang KS, Song YS, et al: Reduced
expression of Apaf-1 in colorectal carcinoma correlates with tumor
progression and aggressive phenotype. Ann Surg Oncol. 14:3453–3459.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Rosmorduc O, Wendum D, Corpechot C, et al:
Hepatocellular hypoxia-induced vascular endothelial growth factor
expression and angiogenesis in experimental biliary cirrhosis. Am J
Pathol. 155:1065–1073. 1999. View Article : Google Scholar
|
|
19.
|
Dubrovska A, Kim S, Salamone RJ, et al:
The role of PTEN/Akt/PI3K signaling in the maintenance and
viability of prostate cancer stem-like cell populations. Proc Natl
Acad Sci USA. 106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kim KH, Choi JS, Kim JM, et al: Enhanced
CD24 expression in endometrial carcinoma and its expression pattern
in normal and hyperplastic endometrium. Histol Histopathol.
24:309–316. 2009.PubMed/NCBI
|
|
21.
|
Press MF, Hung G, Godolphin W and Slamon
DJ: Sensitivity of HER-2/neu antibodies in archival tissue samples:
potential source of error in immunohistochemical studies of
oncogene expression. Cancer Res. 54:2771–2777. 1994.
|
|
22.
|
Yada K, Shibata K, Matsumoto T, Ohta M,
Yokoyama S and Kitano S: Protease-activated receptor-2 regulates
cell proliferation and enhances cyclooxygenase-2 mRNA expression in
human pancreatic cancer cells. J Surg Oncol. 89:79–85. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Sadahiro S, Suzuki T, Maeda Y, et al:
Predictors of tumor down-sizing and regression with pre-operative
radiotherapy alone and with concomitant tegafur/uracil (UFT) for
resectable advanced rectal adenocarcinoma. Hepatogastroenterology.
54:1107–1112. 2007.
|
|
24.
|
Japanese Society for Cancer of the Colon
and Rectum: General Rules for Clinical and Pathological Studies on
Cancer of the Colon, Rectum and Anus: The 7th edition, revised
version. Tokyo: Kanehara; 2009
|
|
25.
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ieta K, Tanaka F, Haraguchi N, et al:
Biological and genetic characteristics of tumor-initiating cells in
colon cancer. Ann Surg Oncol. 15:638–648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Weichert W, Denkert C, Burkhardt M, et al:
Cytoplasmic CD24 expression in colorectal cancer independently
correlates with shortened patient survival. Clin Cancer Res.
11:6574–6581. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
32.
|
Uchida N, Buck DW, He D, et al: Direct
isolation of human central nervous system stem cells. Proc Natl
Acad Sci USA. 97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Bhatia M: AC133 expression in human stem
cells. Leukemia. 15:1685–1688. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
35.
|
Fischer GF, Majdic O, Gadd S and Knapp W:
Signal transduction in lymphocytic and myeloid cells via CD24, a
new member of the phosphoinositol-anchored membrane molecules. J
Immunol. 144:638–641. 1990.PubMed/NCBI
|
|
36.
|
Jackson D, Waibel R, Weber E, Bell J and
Stahel RA: CD24, a signal-transducing molecule expressed on human B
cells, is a major surface antigen in small-cell lung carcinomas.
Cancer Res. 52:5264–5270. 1992.
|
|
37.
|
Akashi T, Shirasawa T and Hirokawa K: Gene
expression of CD24 core polypeptide molecule in normal rat tissues
and human tumor cell lines. Virchows Arch. 425:399–406. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Roh MS, Colangelo LH, O'Connell MJ, et al:
Pre-operative multimodality therapy improves disease-free survival
in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol.
27:5124–5130. 2009. View Article : Google Scholar : PubMed/NCBI
|
